PL3685167T3 - Sposób diagnozy i prognozy chorób neurodegeneracyjnych i neurozapalnych - Google Patents
Sposób diagnozy i prognozy chorób neurodegeneracyjnych i neurozapalnychInfo
- Publication number
- PL3685167T3 PL3685167T3 PL18789217T PL18789217T PL3685167T3 PL 3685167 T3 PL3685167 T3 PL 3685167T3 PL 18789217 T PL18789217 T PL 18789217T PL 18789217 T PL18789217 T PL 18789217T PL 3685167 T3 PL3685167 T3 PL 3685167T3
- Authority
- PL
- Poland
- Prior art keywords
- prognosis
- neurodegenerative
- diagnosis
- neuroinflammatory diseases
- neuroinflammatory
- Prior art date
Links
- 208000036110 Neuroinflammatory disease Diseases 0.000 title 1
- 238000003745 diagnosis Methods 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 208000015122 neurodegenerative disease Diseases 0.000 title 1
- 230000000626 neurodegenerative effect Effects 0.000 title 1
- 238000004393 prognosis Methods 0.000 title 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
- G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N1/00—Sampling; Preparing specimens for investigation
- G01N1/28—Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/178—Oligonucleotides characterized by their use miRNA, siRNA or ncRNA
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/28—Neurological disorders
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/28—Neurological disorders
- G01N2800/2814—Dementia; Cognitive disorders
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/28—Neurological disorders
- G01N2800/2814—Dementia; Cognitive disorders
- G01N2800/2821—Alzheimer
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Analytical Chemistry (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pathology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Physics & Mathematics (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Organic Chemistry (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- General Physics & Mathematics (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT102017000105483A IT201700105483A1 (it) | 2017-09-21 | 2017-09-21 | Metodo per la diagnosi e la prognosi di patologie neurodegenerative e neuroinfiammatorie |
| PCT/IB2018/057261 WO2019058303A1 (en) | 2017-09-21 | 2018-09-20 | DIAGNOSTIC AND PROGNOSTIC METHODS FOR NEURODEGENERATIVE AND NEUROINFLAMMATORY DISEASES |
| EP18789217.9A EP3685167B1 (en) | 2017-09-21 | 2018-09-20 | Method for the diagnosis and prognosis of neurodegenerative and neuroinflammatory diseases |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL3685167T3 true PL3685167T3 (pl) | 2022-03-07 |
Family
ID=61024877
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL18789217T PL3685167T3 (pl) | 2017-09-21 | 2018-09-20 | Sposób diagnozy i prognozy chorób neurodegeneracyjnych i neurozapalnych |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US11359243B2 (pl) |
| EP (1) | EP3685167B1 (pl) |
| CN (1) | CN111279196B (pl) |
| CA (1) | CA3076316A1 (pl) |
| ES (1) | ES2905144T3 (pl) |
| IT (1) | IT201700105483A1 (pl) |
| PL (1) | PL3685167T3 (pl) |
| WO (1) | WO2019058303A1 (pl) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP7448831B2 (ja) * | 2019-11-29 | 2024-03-13 | 富士フイルム和光純薬株式会社 | アルツハイマー型認知症又は軽度認知障害の診断を補助する方法、バイオマーカー、試薬キット及び装置 |
| WO2023280294A1 (zh) * | 2021-07-08 | 2023-01-12 | 北京干细胞与再生医学研究院 | 用于治疗神经退行性疾病或中枢神经系统损伤的靶点及小分子化合物 |
| WO2023232108A1 (zh) * | 2022-06-02 | 2023-12-07 | 浙江大学医学院附属第一医院 | 诊断及鉴别诊断非阿尔兹海默病认知障碍的方法、系统、组合物和试剂盒 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2003105882A (ru) * | 2000-08-04 | 2005-01-20 | Лома Линда Юниверсити Медикал Сентер (Us) | Упорядоченный железосодержащий белок-2 в качестве диагностического средства при нейродегенеративных заболеваниях |
| TWI788704B (zh) * | 2013-10-24 | 2023-01-01 | 美商納諾索米克斯公司 | 分析個體樣品之方法 |
-
2017
- 2017-09-21 IT IT102017000105483A patent/IT201700105483A1/it unknown
-
2018
- 2018-09-20 WO PCT/IB2018/057261 patent/WO2019058303A1/en not_active Ceased
- 2018-09-20 CN CN201880069312.4A patent/CN111279196B/zh active Active
- 2018-09-20 CA CA3076316A patent/CA3076316A1/en active Pending
- 2018-09-20 PL PL18789217T patent/PL3685167T3/pl unknown
- 2018-09-20 US US16/649,247 patent/US11359243B2/en active Active
- 2018-09-20 EP EP18789217.9A patent/EP3685167B1/en active Active
- 2018-09-20 ES ES18789217T patent/ES2905144T3/es active Active
Also Published As
| Publication number | Publication date |
|---|---|
| WO2019058303A1 (en) | 2019-03-28 |
| CN111279196A (zh) | 2020-06-12 |
| CA3076316A1 (en) | 2019-03-28 |
| US11359243B2 (en) | 2022-06-14 |
| CN111279196B (zh) | 2023-07-14 |
| US20200216902A1 (en) | 2020-07-09 |
| EP3685167A1 (en) | 2020-07-29 |
| IT201700105483A1 (it) | 2019-03-21 |
| EP3685167B1 (en) | 2021-11-10 |
| ES2905144T3 (es) | 2022-04-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL276893A (en) | Systems and methods for detecting residual disease | |
| SG11202001633UA (en) | Diagnosis assistance system and control method therefor | |
| ZA201803907B (en) | System and method of determining the health & gender of a chick | |
| SG11202000387YA (en) | B7-h4 antibodies and methods of use thereof | |
| GB201813459D0 (en) | Transaction system and method of operation thereof | |
| IL256685B (en) | An isolated tau-binding antibody and its use in the treatment and diagnosis of tauopathy | |
| GB201715362D0 (en) | Systems and methods for automated evaluation of human speech | |
| EP3629992A4 (en) | METHOD OF SUPPORT FOR ORTHODONTICS AND SUPPORT SYSTEM FOR ORTHODONTICS | |
| SG10201600938YA (en) | Method And System For Point Of Sale Payments | |
| EP3117180A4 (en) | Real-time digitally enhanced imaging for the prediction, application, and inspection of coatings | |
| GB201600873D0 (en) | System and method for endoscope callibration | |
| GB201718238D0 (en) | Method and system for determining the disease status of a subject | |
| GB2567750B (en) | System and method for sensing tissue deformation | |
| GB201818741D0 (en) | Diagnostic system and method | |
| GB201500875D0 (en) | Antibodies for treatment and diagnosis | |
| IL266106A (en) | Monoclonal antibody and method of use for treatment of lupus | |
| HUE062956T2 (hu) | Eljárások niraparib és köztitermékei elõállítására | |
| EP3430406B8 (en) | Method for cancer diagnosis and prognosis | |
| EP3229020A4 (en) | In-vitro method and kit for diagnosing the risk of suffering from caries | |
| IL272837A (en) | A process for preparing tubolysins and their intermediates | |
| IL273086A (en) | Imaging system and method therefor | |
| IT201700105483A1 (it) | Metodo per la diagnosi e la prognosi di patologie neurodegenerative e neuroinfiammatorie | |
| EP3734277A4 (en) | PROCESS FOR EVALUATING A MEDICINAL PRODUCT | |
| HUE059900T2 (hu) | Eljárások aneurizma vagy rák diagnosztizálására | |
| EP3283457A4 (en) | Compounds and methods for the treatment of neurodegenerative diseases |